The original account or authority
Writing from New Jersey, Derek Jason LeCompte describes a cellmate exhibiting alarming symptoms after suspected K2 use. His Prison Journalism Project opinion describes the substance as a major safety problem. It is a firsthand narrative, not independently confirmed toxicology or a study of prevalence in every correctional facility.
What remains uncertain
Products called K2 can contain synthetic chemicals of unpredictable potency. Staff responses to medical emergencies, laboratory testing, health follow-up and treatment options deserve independent scrutiny. A prison's published incident total depends on how suspected and confirmed cases are counted.
What readers should know
LeCompte proposes allowing cannabis edibles as harm reduction. This is his controversial policy suggestion, not an approved treatment for poisoning or a change in prison law. Prison Project can examine actual Georgia, Alabama and Florida response protocols without endorsing self-treatment or assuming every reported episode involved the same substance.
Primary source: Derek Jason LeCompte, Prison Journalism Project, October 8, 2026.
Original Prison Project report prepared October 12, 2026. Distinguish legal holdings from opinions and allegations. Families can bring documented concerns to PrisonProject.net. Remove private identifiers from material intended for publication.
Comments